Articles by Merrill Goozner

Stopping Hookworm As trials get underway in Brazil, Peter Hotez and his colleagues are hoping their vaccine will put an end to a parasite's evasive immune maneuvers - and its devastating morbidity. By Merrill Goozner Related Articles 1 "The likelihood of success is not very high. This is a complex parasite that has evolved over a million years." In 1989, Hotez moved to Yale University, where he conducted most of the early scientific w

Beating Malaria Mang We Tin with her feverish five-year-old son Hla Win Tun awaiting treatment at a clinic in Mawker Tie. Nicholas White and François Nosten have shown that artemisinin in combination with other drugs are 90% effective at fighting the scourge of the world. So why isn't everyone using it? By Merrill Goozner ARTICLE EXTRAS 1 Yet there is still little understanding of how artemisinin-based derivatives and the other drugs used i

The first 13-year-old patient   By Merrill Goozner FEATURE ARTICLE Beating MalariaNicholas White and François Nosten have shown that drugs in combination with artemisinin are 90% effective at fighting the scourge of the world. So why isn't everyone using it? MERRILL GOOZNER travels to Thailand and China to watch Nosten and White at work. ARTICLE EXTRAS A military outbreak spurs researchIn September 2003, the US 26th Marine Expeditionary Unit entered Liberia for a

A military outbreak spurs research By Merrill Goozner FEATURE ARTICLE 1 However, their study used a Chinese version of the drug, which doesn't meet western manufacturing standards, and thus can't be used by the US military or purchased by aid agencies for the developing world. 1. South East Asian Quinine Artesunate Malarial Trial (SEAQUAMAT) group, "Artesunate versus quinine for treatment of severe falciparum malaria: a randomized trial," Lancet, 366:717-25, 2

FDA advisory committee not satisfied with available data on cloned animal products

Congressional Democrats warn of outsourcing plan's effect on science, security, and morale